CoreAge Rx sells the terms rather than the number, and for tirzepatide specifically that is the right emphasis — because tirzepatide is the molecule where dose-based re-rating does the most financial damage.
Compounded tirzepatide is priced at $129 a month on a 12-month plan on CoreAge Rx's product page, with no membership fee, no sign-up fee and no subscription. The company states the price you lock in at checkout stays the same for all future months regardless of dose increases — and that all doses cost the same in the first place.
That combination is genuinely unusual. Tirzepatide titrates from 2.5 mg upward in steps, and at providers that price by dose, arriving at a maintenance dose can double or triple what you were quoted. A flat $129 at 2.5 mg and at 15 mg removes the mechanism that produces most of the bill shock in this category.
The pricing problem you need to know about
CoreAge Rx’s tirzepatide rate depends on plan length: $199/month for one month, $159/month for three, $139/month for six and $129/month for twelve. The $129 starting figure is the monthly equivalent for the twelve-month option, not a month-to-month invoice.
Keep the plan term and the entire payment beside the headline rate. At the twelve-month equivalent, tirzepatide is $1,548 for the year. Ask what is charged today, when medication ships, and what the refund policy allows if treatment ends before the term is used.
How payment and refunds work
You are charged before a clinician reviews your case. CoreAge Rx explains this as locking your price and your position in the pharmacy queue, and commits to an automatic full refund if the provider does not approve a prescription. That is a reasonable trade if the refund is honoured, and the company states it is automatic rather than requested.
Once medication has been received, all sales are final — the company attributes this to federal and state law barring medication returns, which is accurate and applies industry-wide. There is no subscription to cancel: the company states you are contacted before a refill is billed rather than charged automatically.
What is not disclosed
Three gaps matter. The partner pharmacies are not named — the FAQ directs you to phone or email to find out who compounds your medication, which is weaker than competitors who publish their 503A partners. No BMI threshold, exclusion list or lab requirement is published, so you cannot self-screen before entering the funnel. And there is no branded route at all, so if you and your clinician decide to move to Zepbound, you are changing providers.
On the other hand, CoreAge Rx discloses something most competitors do not: that its compounded tirzepatide is typically formulated with B-12, and that you can ask for a formulation without it at intake. That is a real disclosure about what is in the vial, and it is more than most of this field offers.
What it actually costs per year
Advertised prices in this category are usually medication only. Add the membership back in and the ranking changes. Pick a provider, or enter the quote you were given.
One-month tirzepatide rate. Starting at $129/month equivalent requires a 12-month plan ($1,548 total); confirm payment and renewal terms.
- First month
- $199
- Every month after
- $199
- Total over 12 months
- $2,388
No membership on this plan, so every dollar goes to medication and care.
Figures are the providers' own published prices as of our last review of each. Promotional rates, multi-month prepayment and dose changes can all move these numbers — confirm at checkout.
What compounded tirzepatide actually is
Tirzepatide is the active ingredient in Mounjaro and Zepbound, both FDA-approved products from Eli Lilly. Unlike semaglutide, it acts on two receptors — GLP-1 and GIP — which is the basis for the larger average weight reductions seen in its trials. A compounded version is prepared by a pharmacy and is not FDA-approved or FDA-evaluated.
Compounded tirzepatide is consistently more expensive than compounded semaglutide, typically by $50 to $100 a month. That gap is real and reflects the raw material, so a provider pricing them identically is worth a question rather than a celebration.
Dosing usually starts at 2.5 mg weekly and escalates in 2.5 mg steps. As with semaglutide, dose-flat pricing is worth substantially more than a low starting price, because the starting dose is not the dose most people end up on.
Side effects mirror semaglutide's — predominantly gastrointestinal, worst after dose increases — though some patients report tirzepatide is better tolerated at equivalent efficacy. That is an individual matter and not something a telehealth intake form can predict for you.
Before you buy from anyone
- Get the total monthly cost in writing — medication plus any membership, not the headline figure.
- Ask whether the price changes as your dose increases. This is where most of the money is lost.
- Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
- Confirm what happens if you stop after one month, and whether there is an auto-rebill.
- Ask whether a refund is available if a provider declines to prescribe.
- Tell the prescriber every medication and supplement you take, including anything bought online.